Management of Metastatic Bladder Tumours
Regimens Reference N OR (%) CR (%) Survival (months) P MVAC [6] 120 36 13 12.5 <0.0002 Cisplatin 126 11 3 8.2 MVAC [7] 55 65 35 12.6 <0.05 CISCA…
Regimens Reference N OR (%) CR (%) Survival (months) P MVAC [6] 120 36 13 12.5 <0.0002 Cisplatin 126 11 3 8.2 MVAC [7] 55 65 35 12.6 <0.05 CISCA…
1. Muscle invasive (≥T2) bladder cancer 2. Select patients with recurrent high grade T1 or CIS 3. BCG and intravesical chemotherapy failures: high grade T1, with concomitant CIS, multifocal disease…
Parameter Limitation Examples Laboratory methodology New assay system Standardization in progress What is “normal”? Optimal technology? e.g. I-H vs. FISH? e.g. RNA vs. protein? Inter-laboratory variation Lab test applied to…
Fig. 13.1 Cell cycle (Reprinted from Kalmadi and Raghavan [43]. With permission from Springer Verlag) 1. Cells remain quiescent in a resting phase (G0), which may be prolonged over years;…
Fig. 16.1 Comparison of emotional distress by cancer site Hinz and colleagues [11] looked at the degree of psychological distress (anxiety and depression) in urological cancer patients over a period…
57. Herr HW, Dalbagni G. Defining bacillus Calmette-Guerin refractory superficial bladder tumors. J Urol. 2003;169(5):1706–8.PubMed 58. Solsona E, Iborra I, Dumont R, et al. The 3-month clinical response to intravesical…
Variable 0 1 2 3 Primary site Gonadal Retroperitoneal Mediastinal Response 1st line CR/PRm- PRm+/SD PD PFI >3 months ≤3 months AFP at salvage normal <1,000 >1,000 LBB at salvage…
© Springer-Verlag London 2015Vinod H. Nargund, Derek Raghavan and Howard M. Sandler (eds.)Urological Oncology10.1007/978-0-85729-482-1_30 30. The Role of Radiotherapy in Testicular Cancer Sophie D. Fossa1 and Jan Oldenburg2 (1) Department of Oncology, Oslo University Hospital, Montebello, Oslo, Norway (2)…
Characteristic Risk estimates or comment [reference] Disorders of male development Cryptorchidism Five to nine-fold increased risk, 10 % lifetime risk [11, 12] Disorders of sex development Variable, depends on specific…
Fig. 23.1 (a) Central 2.2 cm tumour abutting the collecting system. 6 F ureteric catheter has been inserted and noted next to the lesion. (b) The RF probe is inserted…